Doliracetam
(No INN, CAS 84901-45-1)
Doliracetam is a rare, experimental member of the racetam class studied for nootropic potential but never developed commercially. Publicly available research is extremely limited.
Formula
C₁₆H₁₄N₂O₂
Category
Racetam / Arylpyrrolidone
Molar Mass
266.30 g/mol
Legal Status
Unscheduled, research only
Chemical Profile
Mechanism of Action
Doliracetam’s mechanism is presumed to be consistent with other racetams (AMPAkine-like or cholinergic/neuronal modulation), but no peer-reviewed mechanism-of-action studies are published.
Preclinical Evidence
Structure and Research Resources
Only limited data are available for Doliracetam beyond chemical structure. PubChem and ChEMBL contain basic pharmacological registration and chemical information, but there are no published cognition or clinical animal studies as of 2024.
Safety & Side Effects
No animal, toxicology, or clinical safety data have been published for Doliracetam. It should be handled as a research compound only.
Regulatory & Legal Status
US/EU/International
- Not FDA or EU approved
- Not scheduled or controlled in most regions
- Sold as a research chemical only
Note: Doliracetam is unapproved and not for human use.
History
Doliracetam appears in chemical and pharmacological registries as a member of the racetam family but has no known published cognitive studies or commercial development history.
Premium Doliracetam
Enhance your cognitive performance with science-backed, high-quality nootropics.
Benefits
- Member of the racetam research family
- Aryl pyrrolidone scaffold for SAR studies
- Nootropic compound of chemical curiosity
Considerations
- No published in vivo cognitive/proof data
- No FDA/EU approval
- Research use only; not for human consumption
Free shipping on orders above $50
Scientific References
For chemical research and education only. Not for human use. Last updated: 5/9/2025.